Another Revolution Needed?

Counting the many plagues that threaten research in the Middle East and North Africa region

By | March 1, 2011

NASAScientists around the world face obstacles during their research—a rejected manuscript, a failed funding application, an illegible electrophoresis gel. But these annoyances are simply par for the course when doing science. In the Middle East, however, scientists are up against much steeper challenges—a lesson I learned all too well when I finished my PhD and postdoc at the University of Glasgow in the United Kingdom and returned to my native Kuwait.

In Glasgow, research was facilitated and encouraged. We had several well-trained technicians, up-to-date equipment, and a reasonable amount of funding to support our work. But when I moved home in 1999, full of energy, enthusiasm, and patriotism, I was disappointed to find that science here was not nearly as well supported. Not only is funding hard to come by, excessive regulations can actively slow the process of doing science.

I’ve stayed because I am driven by the need to serve my people, and to explore their unique genetic background. The population of the Middle East and North Africa (MENA) region is a mixture of many cultures that encompasses considerable genetic diversity. Moreover, many MENA populations exhibit unusual rates of consanguineous marriage—as high as 70 percent in some areas. Such behavior has generated atypical populations with very high incidences of rare genetic diseases that are truly valuable for scientific discovery.

Diabetes in the Arabian Gulf states, for example, affects some 20 percent of the population—significantly higher than the 4–6 percent prevalence rates in other parts of the world—and there is strong evidence that it’s a recessive trait. This month, I will present data at the Human Genome Organization conference in Dubai deciphering for the first time the Arabian genome, which my colleagues and I found to contain many long runs of homozygosity that could explain the high incidence of diabetes in this area.

Unfortunately, this type of research is not valued in the MENA region. Here, governments devote less than 1 percent of their gross domestic product to research and development. While funding is a universal challenge in science, this is a meager share compared to the 2-4 percent allocated by Western societies. Those in power here seem to focus on the short-term gains they can achieve from building construction and leasing; they fail to recognize that, oil aside, drugs like Lipitor and Viagra have the potential to generate more money than most economies in the MENA region put together.

A number of recent efforts seek to improve this status, such as Qatar’s dedication of 2.8 percent of its GDP over five years to research and development, the creation of the EU-Egypt Innovation Fund, and other similar initiatives. However, in the majority of the other MENA countries, including Kuwait, funding remains suboptimal.

The lack of government support can also cause needless logistical headaches. Something as simple as obtaining reagents, for example, can take up to a year, because any research item purchased for more than US$6,000 must be tendered by local agents or companies. It’s an intolerable wait after receiving shipments in Glasgow in as little as a few days, and one that can delay research to the point where I am forced to submit papers for peer review before they are completed to buy time for the necessary reagents to arrive.

Confronted with such hurdles, many MENA scientists decide to move to countries that provide better research environments. Of course this hurts MENA countries’ science, and ultimately their economies. A potential work-around for the obstacles we face here is to collaborate with those who have left, and other scientists abroad, sharing genetic samples of MENA populations with better-equipped labs around the world. Unfortunately, in Kuwait we are not allowed to send samples out for research purposes! Another brick wall.

The only way now is to look forward. The recent turmoil in MENA countries, which began in Tunisia and Egypt, is an avid call for change. Governments need to understand that prosperity comes from the kind of scientific innovation and entrepreneurship that drives economies. The increased spending for research by some MENA countries is encouraging, but the road will be long and requires drastic governmental decisions to improve research infrastructures and introduce science culture into our societies.

Fahd Al-Mulla is the head of molecular pathology at Kuwait University and director of the research core facility (RCF) at the university’s Health Sciences Center.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: DJB


Posts: 1

July 2, 2013

In my view Professor Al-Mulla's comment are heroic and key to the development within MENA. I am not from MENA, but I must tell you all of my experience. Having been offered informally a lecturing position at the University, I set about changing my lecture notes and tutorials to reflect the Arab genome project. I wrote specific software tools to enable the medics, physicians and healthcare workers to hurdle over many from the west and again a foothold in the emerging genomic revolution. I can do this, because of my background working for several leading companies in the NGS interpretation field and also dealing with many frustrated scientists globally.

During this time, I was given sporadic updates that all is well and it is progressing. However, three months later, I was feeling something’s was not right... it takes time and it is progressing was the reply. Finally, after a further three months or so went by and I set a deadline, since another University got wind of my work and decided to offer a position. In Kuwait, I spoke with this... I hate to call him a Division Head, but that was his title... The conversation lasted 2.29 minutes: After being kept on hold for most of that, he said... I past your CV to the departments and none were interested, we do not want you… that was it, after over eight months.

I was stunned by this comment, since I had had emails from several group heads stating ways and means to fund my place and how much the department needed my skills... It was these emails and my respect for my sponsor’s work that kept my interest in the position from the start.

Outside of the mismanagement (the lack of calls, email, general information of how my application was progressing) the basics one would expect from a professional organisation.. I believe, if my sponsor had not made the level of fuss he did, nothing at all would have been happened. This shows a fundamental failure of all the processing within the department and a fundamental problem when new ideas hit old-school ways.

Do not get me wrong, I am no Einstein, but I know I can significantly help and promote Kuwait/MENA and help with many of the issues Prof. Al-Mulla discussed in his article. Besides many gulf regions have 20, 30 or 50 year post oil plans...It makes the research  these teams do very suspect, regardless of how new and shiny the buildings maybe. It saddens me further, when a similar pattern was observed in other MENA regions.

I really feel for those researchers actually from those countries. For myself, I can go home, dust myself down, say well that was strange and bad manned and give advice to people in the West. To heroes like Prof. Al-Mulla and others that stay there and try their best, suffering this needless repression of outdated nepotism, I’m aghast.  Let alone the poor researcher with the only option to abandon MENA for life elsewhere.

I will always defend and stand/sit by Prof. Al-Mulla. A true pioneer for Kuwaiti and MENA development!... PLEASE LISTEN TO HIM!

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham